The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.50
Bid: 12.00
Ask: 13.00
Change: 0.00 (0.00%)
Spread: 1.00 (8.333%)
Open: 12.50
High: 12.50
Low: 12.50
Prev. Close: 12.50
SNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

10 Jan 2020 13:30

RNS Number : 4848Z
Sabien Technology Group PLC
10 January 2020
 

For immediate release

10 January 2020

Sabien Technology Group plc

("Sabien" or the "Company")

Issue of equity

The Board of Sabien is pleased to announce that the placing of 200,000,000 new ordinary shares (the "Placing Shares") with new and existing investors, at a price of 0.15 pence per Placing Share (the "Placing Price") was approved by shareholders at the General Meeting held on 8 January 2020 and the Placing Shares commenced trading on AIM with effect from 9 January 2020 (the "Placing").

As previously announced, the Company's largest shareholder, Truell Intergenerational Family Limited Partnership ("TIG"), subscribed for 20,000,000 Placing Shares at the Placing Price and is now interested in 316,751,623 ordinary shares representing 22.84 per cent. of the enlarged issued share capital. TIG had previously been interested in 25.0 per cent. of the Company's issued share capital and had expressed an interest to subscribe for further new ordinary shares at the Placing Price to maintain its interest at 25.0 per cent. The Board of Sabien has now agreed today to issue 46,666,667 new ordinary shares at the Placing Price to TIG ("Subscription"). Following completion of the Subscription and the further issue of equity set out below, TIG will be interested in 25.0 per cent. of the enlarged issued share capital.

The proceeds of the Subscription amount to £70,000 and will be used to provide additional working capital for the continued development of the Company, in line with its stated strategy. Together with existing cash balances (including the proceeds of the Placing) the Company's current cash balances will amount to approximately £820,000. In order to maximise the Company's cash funds available for new investment, the Board has also agreed today to settle accrued but unpaid directors fees due to Cédriane de Boucaud Truell and Marco Nijhof (amounting to £15,000 each) in new ordinary shares ("Fee Shares"), also to be issued at the Placing Price. Accordingly, the Board has issued 10,000,000 new ordinary shares to each of Cédriane de Boucaud Truell and Marco Nijhof (neither of whom previously held any ordinary shares), and who will each be interested in 0.69 per cent of the enlarged issued share capital of the Company.

Once issued, the Subscription Shares and the Fee Shares (together the "New Shares") will rank pari passu with the Company's existing ordinary shares. Application will be made for the New Shares to be admitted to trading on AIM ("Admission") on or around 16 January 2020. The New Shares in aggregate represent 4.8 per cent. of the current issued share capital of the Company.

Richard Parris said:

"These additional funds further strengthen the Company's position to respond to possible business opportunities and broadens the alignment of Directors interests with those of our shareholders."

Total Voting Rights

In conformity with the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority ("FCA") Sabien announces that as at today's date the Company's issued share capital consists of 1,453,673,157 Ordinary Shares of 0.01p each with voting rights. The Company does not hold any Ordinary Shares in Treasury. Therefore, the total number of Ordinary Shares in the Company with voting rights is 1,453,673,157.

The above figure of 1,453,673,157 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

Special note concerning the Market Abuse Regulation

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014 ("MAR").

The person who arranged for the release of this announcement on behalf of the Company was Richard Parris, Executive Chairman.

For further information:

Sabien Technology Group plc

Richard Parris and Cédriane de Boucaud Truell

+44(0)20 7993 3700

Beaumont Cornish Limited (Nominated Advisor)

Michael Cornish and Roland Cornish

www.beaumontcornish.com

+44(0)20 7628 3396

Peterhouse Capital Limited (Broker)

Duncan Vasey and Lucy Williams

+44(0)20 7469 0930

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Cédriane de Boucaud Truell

2

 

Reason for the notification

 

a)

 

Position/status

 

Director

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

Sabien Technology Group plc

b)

 

LEI

 

213800S5QG1SMGHFHY68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 0.01p each ("Ordinary Shares")

 

Identification code

ISIN: GB00B1FPCD38

 

b)

 

Nature of the transaction

 

Settlement of directors' fees in Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

Price(s)

Volumes(s)

£0.15

10,000,000

 

 

 

d)

 

Aggregated information

n/a

- Aggregated volume

- Price

e)

 

Date of the transaction

 

10 January 2019

f)

 

Place of the transaction

 

London Stock Exchange

XLON

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Marco Nijhof

2

 

Reason for the notification

 

a)

 

Position/status

 

Director

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

 

Sabien Technology Group plc

b)

 

LEI

 

213800S5QG1SMGHFHY68

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary Shares of 0.01p each ("Ordinary Shares")

 

Identification code

ISIN: GB00B1FPCD38

 

b)

 

Nature of the transaction

 

Settlement of directors' fees in Ordinary Shares

c)

 

Price(s) and volume(s)

 

 

Price(s)

Volumes(s)

£0.15

10,000,000

 

 

 

d)

 

Aggregated information

n/a

- Aggregated volume

- Price

e)

 

Date of the transaction

 

10 January 2019

f)

 

Place of the transaction

 

London Stock Exchange

XLON

 

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEKKKBDNBKDBDD
Date   Source Headline
7th Jul 20217:00 amRNSTrading Update
25th Jun 202111:15 amRNSOperational Update
18th Jun 20217:00 amRNSAppointment of Chief Scientific Officer
22nd Apr 20214:41 pmRNSSecond Price Monitoring Extn
22nd Apr 20214:36 pmRNSPrice Monitoring Extension
31st Mar 20215:00 pmRNSTotal Voting Rights
29th Mar 20213:45 pmRNSResult of AGM
25th Mar 20217:00 amRNSHalf-year Report
19th Mar 20218:45 amRNSHolding(s) in Company
11th Mar 20214:57 pmRNSHolding(s) in Company
10th Mar 20217:00 amRNSCorporate Update - US Subsidiary Established
8th Mar 202110:59 amRNSCorporate Update - Contract win
5th Mar 202112:32 pmRNSNotice of Annual General Meeting
5th Mar 20217:00 amRNSAppointment of Chief Financial Officer
3rd Mar 20214:33 pmRNSHolding(s) in Company
3rd Mar 202110:00 amRNSHolding(s) in Company
1st Mar 20215:06 pmRNSHolding(s) in Company
1st Mar 20217:00 amRNSHolding(s) in Company
26th Feb 20215:00 pmRNSTotal Voting Rights
26th Feb 202110:47 amRNSSignificant investment in emerging technology
24th Feb 20212:10 pmRNSHolding(s) in Company
24th Feb 202112:16 pmRNSHolding(s) in Company
23rd Feb 20213:45 pmRNSChange of Registered Office
22nd Feb 202110:35 amRNSResult of General Meeting and Total Voting Rights
12th Feb 20217:00 amRNSHolding(s) in Company
11th Feb 202111:03 amRNSHolding(s) in Company
10th Feb 202111:38 amRNSHolding(s) in Company
3rd Feb 20214:11 pmRNSPlacing and Notice of General Meeting
1st Feb 20217:00 amRNSAppointment of Non-Executive Director
28th Jan 20214:32 pmRNSHolding(s) in Company
28th Jan 20218:14 amRNSHolding(s) in Company
27th Jan 20211:28 pmRNSChange of Substantial Shareholding
27th Jan 20211:26 pmRNSHolding(s) in Company
25th Jan 20217:00 amRNSBoard Changes
20th Jan 20217:30 amRNSRestoration - Sabien Technology Group PLC
20th Jan 20217:00 amRNSWithdrawal from acquisition and other matters
12th Jan 20215:38 pmRNSFrequently asked questions regarding the GM
5th Jan 20217:00 amRNSPosting of Circular and Notice of General Meeting
21st Dec 20205:23 pmRNSHolding(s) in Company
21st Dec 20205:20 pmRNSHolding(s) in Company
2nd Dec 20205:14 pmRNSPosting of Annual Report and Accounts
19th Nov 20207:00 amRNSFinal Results & Update on Proposed Acquisition
5th Nov 20207:00 amRNSChange of Registered Office
2nd Nov 20207:00 amRNSUpdate on Acquisition
14th Sep 20203:30 pmRNSCorporate Update - Contract win
27th Jul 20207:00 amRNSChange of Adviser
27th Jul 20207:00 amRNSUpdate re. Suspension
6th Jul 20207:00 amRNSTrading Update
29th May 202011:15 amRNSManagement Change, Furlough Update
31st Mar 20207:00 amRNSSabien furloughs staff in response to C19 lockdown

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.